Abiopharma

10x Genomics - CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics

New Form 8-K - Microbot Medical Inc. Filed: 2025-09-09 AccNo: 0001641172-25-026942 Size: 13 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting

Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

New Form 8-K - ELUTIA INC. Filed: 2025-09-09 AccNo: 0001104659-25-088481 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Celldex to Present at Morgan Stanley 23rd Annual Global Healthcare Conference

New Form 8-K - Electromed, Inc. Filed: 2025-09-09 AccNo: 0001437749-25-028605 Size: 170 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

SmartVest - Electromed, Inc. Announces Share Repurchase Authorization

CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics

Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia "MIRACLE" Clinical Trial

New Form 6-K - Haleon plc Filed: 2025-09-09 AccNo: 0001654954-25-010518 Size: 39 KB

New Form 8-K - Moleculin Biotech, Inc. Filed: 2025-09-09 AccNo: 0001437749-25-028604 Size: 239 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Volition Signs First Human Out Licensing Deal

New Form DEFA14A - INTENSITY THERAPEUTICS, INC. Filed: 2025-09-09 AccNo: 0001567264-25-000091 Size: 1 MB

New Form DEF 14A - INTENSITY THERAPEUTICS, INC. Filed: 2025-09-09 AccNo: 0001567264-25-000090 Size: 1 MB